DK2916856T4 - Anvendelser af bremelanotid til behandling af seksuel dysfunktion hos kvinder - Google Patents

Anvendelser af bremelanotid til behandling af seksuel dysfunktion hos kvinder Download PDF

Info

Publication number
DK2916856T4
DK2916856T4 DK13851014.4T DK13851014T DK2916856T4 DK 2916856 T4 DK2916856 T4 DK 2916856T4 DK 13851014 T DK13851014 T DK 13851014T DK 2916856 T4 DK2916856 T4 DK 2916856T4
Authority
DK
Denmark
Prior art keywords
bremelanotide
females
treatment
sexual dysfunction
sexual
Prior art date
Application number
DK13851014.4T
Other languages
English (en)
Other versions
DK2916856T3 (da
Inventor
Carl Spana
Robert Jordan
Jeffrey D Edelson
Original Assignee
Palatin Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50628268&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2916856(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Palatin Technologies Inc filed Critical Palatin Technologies Inc
Application granted granted Critical
Publication of DK2916856T3 publication Critical patent/DK2916856T3/da
Publication of DK2916856T4 publication Critical patent/DK2916856T4/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/34Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
DK13851014.4T 2012-11-05 2013-11-05 Anvendelser af bremelanotid til behandling af seksuel dysfunktion hos kvinder DK2916856T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261722511P 2012-11-05 2012-11-05
US201361770535P 2013-02-28 2013-02-28
PCT/US2013/068386 WO2014071339A2 (en) 2012-11-05 2013-11-05 Uses of bremelanotide in therapy for female sexual dysfunction

Publications (2)

Publication Number Publication Date
DK2916856T3 DK2916856T3 (da) 2019-01-14
DK2916856T4 true DK2916856T4 (da) 2024-01-22

Family

ID=50628268

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13851014.4T DK2916856T4 (da) 2012-11-05 2013-11-05 Anvendelser af bremelanotid til behandling af seksuel dysfunktion hos kvinder

Country Status (24)

Country Link
US (7) US9352013B2 (da)
EP (1) EP2916856B2 (da)
JP (1) JP6567971B2 (da)
KR (1) KR102253526B1 (da)
CN (2) CN104755094A (da)
AU (1) AU2013337341B2 (da)
BR (1) BR112015009936A8 (da)
CA (1) CA2890081A1 (da)
DK (1) DK2916856T4 (da)
EA (1) EA032959B9 (da)
ES (1) ES2701444T5 (da)
FI (1) FI2916856T4 (da)
GE (1) GEP20196947B (da)
HK (1) HK1211227A1 (da)
IL (1) IL238276B (da)
MX (1) MX362610B (da)
MY (1) MY179755A (da)
NZ (1) NZ707246A (da)
PH (1) PH12015500915A1 (da)
PL (1) PL2916856T5 (da)
SG (1) SG11201502949QA (da)
UA (1) UA118656C2 (da)
WO (1) WO2014071339A2 (da)
ZA (1) ZA201503128B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11590209B2 (en) * 2020-01-21 2023-02-28 Palatin Technologies, Inc. Use of bremelanotide in patients with controlled hypertension

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235625B2 (en) * 1999-06-29 2007-06-26 Palatin Technologies, Inc. Multiple agent therapy for sexual dysfunction
US6579968B1 (en) * 1999-06-29 2003-06-17 Palatin Technologies, Inc. Compositions and methods for treatment of sexual dysfunction
US7176279B2 (en) 2000-06-28 2007-02-13 Palatin Technologies, Inc. Cyclic peptide compositions and methods for treatment of sexual dysfunction
US7022674B2 (en) 1999-12-16 2006-04-04 Eli Lilly And Company Polypeptide compositions with improved stability
DE60112440T2 (de) * 2000-05-31 2006-04-20 Novo Nordisk A/S Wegwerfbare zweispitzige injektionsnadel
CA2453515A1 (en) 2001-07-11 2003-01-23 Palatin Technologies, Inc. Linear and cyclic melanocortin receptor-specific peptides
BRPI0518961A2 (pt) * 2004-12-09 2008-12-16 West Pharm Serv Inc acoplamento para dispositivo de injeÇço automÁtica
WO2009120656A1 (en) * 2008-03-24 2009-10-01 Palatin Technologies, Inc. Pharmaceutical for ocular indications
EA018630B1 (ru) * 2008-06-09 2013-09-30 Палатин Текнолоджиз, Инк. Специфичные к меланокортиновым рецепторам пептиды для лечения сексуальной дисфункции
WO2011060352A1 (en) * 2009-11-16 2011-05-19 Ipsen Pharma S.A.S. Pharmaceutical compositions of melanocortin receptor ligands
CN103118737B (zh) * 2010-04-21 2015-05-20 艾伯维生物技术有限公司 用于治疗药剂的受控输送的可佩戴自动注射装置

Also Published As

Publication number Publication date
PH12015500915B1 (en) 2015-06-29
CN104755094A (zh) 2015-07-01
EP2916856A4 (en) 2016-06-22
ZA201503128B (en) 2016-11-30
US10286034B2 (en) 2019-05-14
EA201590760A1 (ru) 2015-10-30
US20240335502A1 (en) 2024-10-10
PL2916856T3 (pl) 2019-02-28
EP2916856A2 (en) 2015-09-16
ES2701444T3 (es) 2019-02-22
MX2015005486A (es) 2015-11-13
JP2016503406A (ja) 2016-02-04
ES2701444T5 (es) 2024-05-21
US20190216888A1 (en) 2019-07-18
WO2014071339A2 (en) 2014-05-08
FI2916856T4 (fi) 2024-01-15
MY179755A (en) 2020-11-12
SG11201502949QA (en) 2015-06-29
NZ707246A (en) 2019-03-29
IL238276A0 (en) 2015-06-30
EP2916856B2 (en) 2023-10-18
HK1211227A1 (en) 2016-05-20
US20180085425A1 (en) 2018-03-29
US20220362328A1 (en) 2022-11-17
CN117860866A (zh) 2024-04-12
IL238276B (en) 2020-04-30
GEP20196947B (en) 2019-02-11
WO2014071339A3 (en) 2014-06-12
EP2916856B1 (en) 2018-09-19
BR112015009936A8 (pt) 2019-09-17
US9352013B2 (en) 2016-05-31
US20210060120A1 (en) 2021-03-04
JP6567971B2 (ja) 2019-08-28
US20140378392A1 (en) 2014-12-25
KR102253526B1 (ko) 2021-05-18
PL2916856T5 (pl) 2024-01-29
US9700592B2 (en) 2017-07-11
DK2916856T3 (da) 2019-01-14
AU2013337341B2 (en) 2018-02-22
PH12015500915A1 (en) 2015-06-29
US20150231196A1 (en) 2015-08-20
EA032959B9 (ru) 2019-11-27
CA2890081A1 (en) 2014-05-08
UA118656C2 (uk) 2019-02-25
MX362610B (es) 2019-01-28
KR20150081345A (ko) 2015-07-13
AU2013337341A1 (en) 2015-05-07
EA032959B1 (ru) 2019-08-30
BR112015009936A2 (pt) 2017-07-11

Similar Documents

Publication Publication Date Title
IL285832A (en) Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereof
DK3811943T3 (da) Forbindelse til anvendelse til behandling af øjenlidelser
DK3329884T3 (da) Implanterbar indretning til behandling af glaukom
DK2964315T3 (da) System til behandling af neuromotorisk dysfunktion
DK3382201T3 (da) Flydende legeme-struktur
DK3590566T3 (da) Kropsbåret injektor
DK2838539T3 (da) Østrogenderivater til anvendelse i behandlingen af neurologiske forstyrrelser
DK3086793T3 (da) Anvendelse af oxygenerede cholesterolsulfater (ocs) til behandling af nyredysfunktion
HK1217261A1 (zh) 蜂窩網絡中到互聯網的連接的建立
DK4119569T3 (da) Konjugerede antisense-forbindelser til anvendelse i behandling
IL246162B (en) Angiotensin II, alone or in combination, to treat low blood pressure
DK2807170T3 (da) Phragmalin-limonoider til behandlingen af seksuel dysfunktion
DK2974728T3 (da) Terapeutisk middel til meibomsk dysfunktion
GB201302839D0 (en) Water Treatment
ITRM20120473A1 (it) Use of glycerophosphoinositols for the treatment of septic shock
DK2916856T4 (da) Anvendelser af bremelanotid til behandling af seksuel dysfunktion hos kvinder
HK1209097A1 (en) Water treatment
DK2976089T3 (da) Anvendelse af sedoheptulose til forebyggelse eller behandling af inflammation
TWM475278U (en) Structure of sexual vibrator
ZA201604412B (en) Water treatment
GB201416965D0 (en) Water treatment
GB201321174D0 (en) Erectile dysfunction aid
FI10319U1 (fi) Sovitelma saunan lauteissa
ZA201406350B (en) Water treatment
TWM475516U (en) Improved pump body structure